Study to look for cardiovascular manifestations of COVID
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2020/12/029981
- Lead Sponsor
- Rohit Walia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with COVID 19 disease confirmed by RTPCR
Age greater than 18 years
Exclusion Criteria
Not giving informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of acute myocardial events in COVID-19 population at baseline <br/ ><br>and during hospital stayTimepoint: Incidence of acute myocardial events in COVID-19 population at baseline <br/ ><br>and during hospital stay
- Secondary Outcome Measures
Name Time Method Cardiovascular outcomes : myocardial infarction or stenosis, stroke, pulmonary embolism, deep vein thrombosis, ventricular dysfunction, conduction disorders and sudden deathTimepoint: 14 days till hospitalisation;New-onset cardiac arrhythmiaTimepoint: 14 days since hospitalisation;To evaluate the reversibility or progression of cardiac involvement at 2 months of follow up vs. at discharge timeTimepoint: 2 months